Literature DB >> 18290690

[Fecal calprotectin].

L Rodrigo.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18290690     DOI： 10.4321/s1130-01082007001200001

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN： 1130-0108            Impact factor:   2.086


× No keyword cloud information.
  10 in total

Review 1.  Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility.

Authors:  Edoardo Savarino; Fabiana Zingone; Brigida Barberio; Giovanni Marasco; Filiz Akyuz; Hale Akpinar; Oana Barboi; Giorgia Bodini; Serhat Bor; Giuseppe Chiarioni; Gheorghe Cristian; Maura Corsetti; Antonio Di Sabatino; Anca Mirela Dimitriu; Vasile Drug; Dan L Dumitrascu; Alexander C Ford; Goran Hauser; Radislav Nakov; Nisha Patel; Daniel Pohl; Cătălin Sfarti; Jordi Serra; Magnus Simrén; Alina Suciu; Jan Tack; Murat Toruner; Julian Walters; Cesare Cremon; Giovanni Barbara
Journal:  United European Gastroenterol J       Date:  2022-06-13       Impact factor: 6.866

Review 2.  The role of calprotectin in pediatric disease.

Authors:  George Vaos; Ioannis D Kostakis; Nick Zavras; Athanasios Chatzemichael
Journal:  Biomed Res Int       Date:  2013-09-23       Impact factor: 3.411

3.  Upregulation of calprotectin in mild IgE-mediated ovalbumin hypersensitivity.

Authors:  Qingling Zhu; Feng Li; Junli Wang; Jingqiu Ma; Xiaoyang Sheng
Journal:  Oncotarget       Date:  2017-06-06

Review 4.  From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting.

Authors:  Maria Gloria Mumolo; Lorenzo Bertani; Linda Ceccarelli; Gabriella Laino; Giorgia Di Fluri; Eleonora Albano; Gherardo Tapete; Francesco Costa
Journal:  World J Gastroenterol       Date:  2018-09-07       Impact factor: 5.742

5.  Influence of proton pump inhibitor therapy on intestinal inflammation assessed by fecal calprotectin in pediatric patients.

Authors:  Su Yeong Kim; Na Mi Lee; Sin Weon Yun; Soo Ahn Chae; In Seok Lim; Eung Sang Choi; Dae Yong Yi
Journal:  Korean J Pediatr       Date:  2019-07-03

6.  Association between body mass index and fecal calprotectin levels in children and adolescents with irritable bowel syndrome.

Authors:  Jun Hwan Kim; Dae Yong Yi; Yoo Min Lee; You Jin Choi; Ju Young Kim; Yong Hee Hong; Ji Young Park; Su Yeong Kim; Na Mi Lee; Sin Weon Yun; Soo Ahn Chae; In Seok Lim; Eung Sang Choi; In Sook Jeong
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

7.  Reduced Fecal Calprotectin and Inflammation in a Murine Model of Atopic Dermatitis Following Probiotic Treatment.

Authors:  Myoung-Ju Kim; Ji-Young Kim; Minje Kang; Moo-Ho Won; Seok-Ho Hong; Young Her
Journal:  Int J Mol Sci       Date:  2020-05-31       Impact factor: 5.923

8.  Fecal calprotectin as a marker of gastrointestinal involvement in pediatric Henoch-Schönlein purpura patients: a retrospective analysis.

Authors:  Eun Young Paek; Dae Yong Yi; Ben Kang; Byung-Ho Choe
Journal:  BMC Pediatr       Date:  2020-08-08       Impact factor: 2.125

9.  Fecal Calprotectin: A Comparison of Two Commercial Enzymoimmunoassays and Study of Fecal Extract Stability at Room Temperature.

Authors:  Delia Acevedo; Maria Pilar Salvador; Javier Girbes; Nuria Estan
Journal:  J Clin Med Res       Date:  2018-03-16

10.  Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies: A Prospective Study.

Authors:  Lorenzo Bertani; Corrado Blandizzi; Maria Gloria Mumolo; Linda Ceccarelli; Eleonora Albano; Gherardo Tapete; Giovanni Baiano Svizzero; Federico Zanzi; Francesca Coppini; Nicola de Bortoli; Massimo Bellini; Riccardo Morganti; Santino Marchi; Francesco Costa
Journal:  Clin Transl Gastroenterol       Date:  2020-05       Impact factor: 4.396
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.